Chen H, Zheng R, Le W, et al. Advances in cancer epidemiology in China in 2019. Chin J Dis Control. 2020;24:373–9.
Google Scholar
Sun K, Zheng R, Zhang S, et al. Report of cancer incidence and mortality in different areas of China, 2015. Chin Oncol. 2019;28:1–11.
Google Scholar
Wang J, Yang Y, Geng Y, et al. Trend analysis of incidence, morbidity and mortality of gastric cancer in China 1990–2017. Chron Dis Prev Control Chin. 2020;28:321–32.
Google Scholar
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52(24):6735–40.
CAS
Google Scholar
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–88.
Article
Google Scholar
National digestive disease clinical research center (Shanghai) , National Association of Digestive Tract early cancer prevention and treatment centers, Helicobacter pylori, et al. Chinese consensus on management of gastric epithelial precancerous conditions and lesions (2020). J Chin Dig, 2020;40(11) : 731–741
Society of Gastroenterology, Chinese Medical Association. Consensus opinion on chronic gastritis in China (Shanghai, 2017). Chin J Gastroenterol. 2017;22:670–87.
Google Scholar
Standardized diagnosis and treatment of gastric low-grade intraepithelial neoplasia, division of gastroendoscopy, Beijing Medical Association (2019). Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2019;6: 49–55.
Society of Spleen and stomach diseases. Chinese academy of traditional Chinese medicine. Consensus on clinical application of gastric mucosa biopsy (2018). Chin J Integr Tradit West Med. 2018;38:1496–9.
Google Scholar
Society of Spleen and stomach diseases. Chinese Academy of Traditional Chinese medicine. Consensus opinion of TCM experts on chronic gastritis (2017). Chin J Tradit Chin Med Pharm. 2017;7:3060–4.
Google Scholar
Nagayo T. Histological diagnosis of biopsied gastric mucosae with special reference to that of borderline lesion. Gann Monogr. 1971;11:245–56.
Google Scholar
Serck-Hanssen A. Precancerous lesions of the stomach. Scand J Gastroenterol Suppl. 1979;54:104–5.
CAS
Google Scholar
Fenoglio-Preiser C, Carneiro F, Correa P, et al. Gastric Carcinoma. In: Hamilton SR, Aaltonen LA, editors., et al., World Health Organization classification of tumours: pathology and genetics of tumours of the digastive system. Lyon: IARC Press; 2000. p. 37–52.
Google Scholar
Ning H. Yu J/WHO (2010) histological classification of digestive system tumors. J Diag Pathol. 2011;18:77–9.
Google Scholar
WHO Classification of Tumours Editorial Board. WHO classification of tumours of digestive system[M]. Lyon: IARC Press; 2019.
Google Scholar
Du Y, Bai Y, Xie P, et al. Chronic gastritis in China: a national multi-center survey. BMC Gastroenterol. 2014;7:14–21.
Google Scholar
Zhang H, Xue Y, Zhou L, et al. Evolution of major upper gastrointestinal diseases and Helicobacter pylori infections over a 35 year grade III, class A hospital in Beijing. Chinese Journal of Internal Medicine. 2016;55:6.
Google Scholar
Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657–67.
Article
CAS
Google Scholar
Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25–40.
Article
Google Scholar
Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1083–94.
Article
Google Scholar
Adamu MA, Weck MN, Gao L, et al. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25:439–48.
Article
Google Scholar
Gao L, Weck MN, Raum E, et al. Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany. Int J Epidemiol. 2010;39:129–34.
Article
Google Scholar
Yeh LY, Raj M, Hassan S, et al. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian J Gastroenterol. 2009;28:49–52.
Article
Google Scholar
Nguyen TL, Uchida T, Tsukamoto Y, et al. Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol. 2010;10:114.
Article
Google Scholar
Shen H. Treatment of chronic Atrophic gastritis and precancerous lesions. Jiangsu Tradit Chin Med. 2007;8:6–7.
Google Scholar
Shi S, Lu W. Professor Shan Zhaowei’s experience in treating chronic Atrophic gastritis precancerous lesions. Educ Tradit Chin Med. 1998;17(4):44–46.
Google Scholar
Hu L, Ma J. Prof Lo Siu-yin’s experience in differentiation and treatment of precancerous gastric cancer. New Chin Med. 2006;38(5):7–9.
Google Scholar
Su Z, Zhang W, Zhang Y, et al. Chronic gastritis malignant transformation process syndrome, syndrome element evolution law. Mod Chin Med Clin. 2017;6:9–14.
Google Scholar
Su Z, Li P, Guo Q, et al. Study on the law of TCM syndrome evolution of chronic gastritis. J Beijing Univ Chin Med. 2015;11(762–766):771.
Google Scholar
Cheng R, Cui Y, Chen L, et al. Study on regularity of TCM syndrome types of chronic Atrophic gastritis precancerous lesions based on logistic regression model. Chin J Tradit Chin Med. 2018;33(8):3623–6.
Google Scholar
Chao J, Zhen X, Liu S. Study on the evolution of TCM syndromes of chronic Atrophic gastritis. Beijing Tradit Chin Med. 2019;1:48–50.
Google Scholar
Yao K, Naghama T, Matsui T, et al. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection. Dig Endosc. 2013;25:44–54.
Article
Google Scholar
Kenshi Y, Noriya U, Tomoari K, et al. (JGES Guidelines) Guidelines for Endoscopic Diagnosis of Early Gastric Cancer. Dig Endosc. 2020;32(5):663–98.
Article
Google Scholar
Bertoni G, Gumina C, Conigliaro R, et al. Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. Endoscopy. 1992;24:268–70.
Article
CAS
Google Scholar
Lee GJ, Park SJ, Kim SJ, et al. Effectiveness of premedication with pronase for visualization of the mucosa during endoscopy: a randomized, controlled trial. Clin Endosc. 2012;45:161–4.
Article
Google Scholar
Lee SY, Han HS, Cha JM, et al. Endoscopic flushing with pronase improves the quantity and quality of gastric biopsy: a prospective study. Endoscopy. 2014;46:747–53.
Article
Google Scholar
Kim GH, Cho YK, Cha JM, et al. Effect of pronase as mucolytic agent on imaging quality of magnifying endoscopy. World J Gastroenterol. 2015;21:2483–9.
Article
CAS
Google Scholar
Chen X, Chu G, Lu C, et al. Value of combination of dimethylsiloxane powder and chymotrypsin in gastroscopy [J ]. Chongqing Med. 2018;47(20):2744–6.
Google Scholar
Liu X, Guan CT, Xue LY, et al. Effect of premedication on lesion detection rate and visualization of the mucosa during upper gastrointestinal endoscopy: a multicenter large sample randomized controlled double-blind study. Surg Endosc. 2018;32(8):3548–56.
Article
CAS
Google Scholar
Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol. 2013;26:11–22.
Google Scholar
Hiki N, Kurosaka H, Tatsutomi Y, et al. Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial. Gastrointest Endosc. 2003;57:475–82.
Article
Google Scholar
Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007;133(2):675–701.
Article
CAS
Google Scholar
Obara K, Haruma K, Irisawa A, et al. Guidelines for sedation in gastroenterological endoscopy. Digest Endosc. 2015;27:435–49.
Article
Google Scholar
Probert CS, Jayanthi V, Quinn J, et al. Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract. Endoscopy. 1991;23(4):218–9.
Article
CAS
Google Scholar
Gastroenterologist branch of Chinese Medical Doctor Association.painless endoscopy. Chinese Journal of Practical Internal Medicine. 2010; 30(7): 605–607.
Panteris V, Nikolopoulou S, Lountou A, et al. Diagnostic capabilities of high-definition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data. Eur J Gastroenterol Hepatol. 2014;26:594–601.
Article
Google Scholar
Pimentel-Nunes P, Libanio D, Lage J, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 2016;48:723–30.
Article
Google Scholar
Zhao Z, Yin Z, Wang S, et al. Meta-analysis: the diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions. J Gastroenterol Hepatol. 2016;31(9):1539–45.
Article
Google Scholar
Kikuste I, Marques-Pereira R, Monteiro-Soares M, et al. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol. 2013;48:1108–17.
Article
Google Scholar
Ang TL, Pittayanon R, Lau JY, et al. A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions. Eur J Gastroenterol Hepatol. 2015;27:1473–8.
Article
Google Scholar
Dutta AK, Sajith KG, Pulimood AB, et al. Narrow band imaging versus white light gastroscopy in detecting potentially premalignant gastric lesions: a randomized prospective crossover study. Indian J Gastroenterol. 2013;32:37–42.
Article
Google Scholar
Le FW, Wang XS, Yin W. Value of electronic staining combined with indigo carmine staining in the diagnosis of early gastric cancer and precancerous lesions. Gansu Med. 2017;36:44–5.
Google Scholar
Zhang LiY. Application of NBI combined with acetic acid and methylene blue staining in early gastric cancer and precancerous lesions. Fujian Med J. 2018;40:38–40.
Google Scholar
Zhang Y, Zhang L, Liang YY. Endoscopic acetic acid staining combined with narrow band light imaging in the diagnosis of early gastric cancer and precancerous lesions. Clin Med. 2019;39:49–50.
Google Scholar
Kentaro S, Jan T, Ernst JK, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–67.
Article
Google Scholar
Banks M, Graham D, Jansen M, et al. British society of gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68(9):1545–75.
Article
Google Scholar
Division of pathology. Chinese society of digestive endoscopy, Chinese society of digestive endoscopy, expert consensus (Draft). Chinese Journal of Digestion. 2014;34(9):577–81.
Google Scholar
Preparatory group of digestive pathology group, Pathology branch, Chinese Medical Association. Consensus of pathological diagnosis of gastric mucosa biopsy in chronic gastritis and epithelial tumor. Chin J Pathol. 2017;46(5):289–93.
Google Scholar
Lash JG, Genta RM. Adherence to the Sydney system guidelines increases the detection of Helicobacter gastritis and intestinal metaplasia in 400738 sets of gastric biopsies. Aliment Pharmacol Ther. 2013;38:424–31.
Article
CAS
Google Scholar
Kwack WG, Ho WJ, Kim JH, et al. Understanding the diagnostic yield of current endoscopic biopsy for gastric neoplasm: a prospective single-center analysis based on tumor characteristics stratified by biopsy number and site. Medicine. 2016;95: e41967.
Article
Google Scholar
Januszewicz W, Wieszczy P, Bialek A, et al. Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation. GastrointestEndosc. 2019;89:1141–9.
Google Scholar
Sun LM, Si JM, Chen SJ, et al. The setablishment and clinical appliance of technique of mucosa marking targeting biopsy. Hepatogastroenterology. 2009;56(89):59–62.
Google Scholar
Sun LM, Si JM, Fan YJ. Experimental study on one-step endoscopic calibration biopsy. J Chin Dig. 2006;26:488–9.
Google Scholar
Liu HY, Chen YC, Qing P, et al. The effect of Banxia xiexin decoction on chronic Atrophic gastritis was evaluated by standard biopsy technique. Chin Arch Tradit Chin Med. 2014;32:804–7.
Google Scholar
Society of Digestive diseases, Chinese medical association. Consensus on chronic gastritis in China (2012). Chin J Dig Endosc. 2013;18(1):24–36.
Wu YQ, Lin Q, Sun X, et al. The value of scaling biopsy in follow-up of gastric mucosal lesion. Chin J Dig Endosc. 2016;33:551–3.
Google Scholar
Kim CG. Tissue acquisition in gastric epithelial tumor prior to endoscopic resection. Clin Endosc. 2013;46(5):436–40.
Article
Google Scholar
Graham DY, Schwartz JT, Cain GD, et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology. 1982;82(2):228–31.
Article
CAS
Google Scholar
Society of gastroendoscopy, Chinese Medical Association, Professional committee of Tumor Endoscopy, Chinese anti-cancer association. Consensus opinion on early gastric cancer screening and endoscopy in China (Changsha, 2014). Chin J Dig Endosc. 2014;31:361–77.
Google Scholar
Wakita S, Takemura K, Minato H, et al. Optimal number of endoscopic biopsies for diagnosis of early gastric cancer. Endosc Int Open. 2019;7(12):E1683-1690.
Article
Google Scholar
Yao K, Doyama H, Gotoda T, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. 2014;17(4):669–79.
Article
Google Scholar
Chiu PWY, Uedo N, Singh R, et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut. 2019;68(2):186–97.
Article
Google Scholar
Koyama H-N. Methods and strategies for endoscopic diagnosis of early gastric cancer. 2017;1:29–32.
Filipe MI, Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 1994;57:324–9.
Article
CAS
Google Scholar
Conchillo JM, Houben G, de Bruïne A, et al. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? Eur J Cancer Prev. 2001;10:307–312.
Article
CAS
Google Scholar
Piazuelo MB, Camargo MC, Mera RM, et al. Gastric intestinal metaplasia type III and prospective risk of gastric cancer in colombia. Gastroenterology. 2017;152:S473.
Article
Google Scholar
Shah SC, Gawron AJ, Mustafa R, et al. Histologic subtyping of gastric intestinal metaplasia: overview and considerations for clinical practice. Gastroenterology. 2020;158(3):745–750.
Article
Google Scholar
Bolscher J, Sobrinho SIMESM. Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch. 2002;440:311–7.
Article
Google Scholar
Duan XJ, Lian HW, Li J, et al. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia. Diagn Pathol. 2019;14:61.
Article
Google Scholar
Dong B, Xie Y-Q, KeChen, et al. Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions. World J Gastroenterol. 2005;11(23):3595–600.
Article
Google Scholar
Baldus SE, Monig SP, Arkenau V, et al. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann Surg Oncol. 2002;9:887–93.
Article
Google Scholar
Simone A, Casadei A, De Vergori E, et al. Rescue endoscopy to identify site of gastric dysplasia or carcinoma found at random biopsies. Dig Liver Dis. 2011;43(9):721–5.
Article
Google Scholar
De Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134(4):945–52.
Article
Google Scholar
Akbari M, Kardeh B, Tabrizi R, et al. Incidence rate of gastric cancer adenocarcinoma in patients with gastric dysplasia: a systematic review and meta-analysis. J Clin Gastroenterol. 2019;53(10):703–10.
Article
Google Scholar
Lim H, Jung HY, Park YS, et al. Discrepancy between endoscopic forceps biopsy and endoscopic resection in gastric epithelial neoplasia. Surg Endosc. 2014;28(4):1256–62.
Article
Google Scholar
Zhao G, Xue M, Hu Y, et al. How commonly is the diagnosis of gastric low grade dysplasia upgraded following endoscopic resection? A meta-analysis. PLoS ONE. 2015;10(7):e0132699.
Article
Google Scholar
Wu B, Ling HEQ, Yang J, et al. Clinical pathology and prognosis of low grade intraepithelial neoplasia of gastric mucosa. J Mil Med Cont Edu Coll. 2011;32(6):598–600.
CAS
Google Scholar
Goo JJ, Choi CW, Kang DH, et al. Risk factors associated with diagnostic discrepancy of gastric indefinite neoplasia: who need en bloc resection? Surg Endosc. 2015;29(12):3761–7.
Article
Google Scholar
Raftopoulos SC, Kumarasinghe P, de Boer B, et al. Gastric intraepithelial neoplasia in a Western population. Eur J Gastroenterol Hepatol. 2012;24(1):48–54.
Article
Google Scholar
Fassan M, Pizzi M, Farinati F, et al. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol. 2012;137(5):727–32.
Article
Google Scholar
Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary group on gastric epithelial dysplasia. Gastroenterology. 1994;107(5):1288–96.
Article
CAS
Google Scholar
Rugge M, Cassaro M, Di Mario F, et al. Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED). The long term outcome of gastric non-invasive neoplasia. J Gut. 2003;52(8):1111–6.
Article
CAS
Google Scholar
Kapadia CR. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol. 2003;36(5 Suppl):S29-36.
Article
Google Scholar
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
Article
CAS
Google Scholar
Fukao A, Hisamichi S, Ohsato N, et al. Correlation between the prevalence of gastritis and gastric cancer in Japan. Cancer Causes Control. 1993;4(1):17–20.
Article
CAS
Google Scholar
Genta RM. Review article: gastric atrophy and atrophic gastritis–nebulous concepts in search of a definition. Aliment Pharmacol Ther. 1998;12(Suppl 1):17–23.
Article
Google Scholar
Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–24.
Article
Google Scholar
Lahner E, Esposito G, Pilozzi E, et al. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol. 2015;50(7):856–65.
Article
CAS
Google Scholar
Reddy KM, Chang JI, Shi JM, et al. Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US integrated health care system. Clin Gastroenterol Hepatol. 2016;14(10):1420–5.
Article
Google Scholar
Zhou Y, Li HY, Zhang JJ, et al. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol. 2016;22(13):3670–8.
Article
Google Scholar
Kodama M, Murakami K, Okimoto T, et al. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol. 2013;48(11):1249–56.
Article
Google Scholar
Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16(2):e60-70.
Article
Google Scholar
Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer. 2010;102(2):237–42.
Article
CAS
Google Scholar
Safaee A, Moghimi-Dehkordi B, Fatemi SR, et al. Family history of cancer and risk of gastric cancer in Iran. Asian Pac J Cancer Prev. 2011;12(11):3117–20.
CAS
Google Scholar
Masuyama H, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91(1):30–6.
Article
Google Scholar
Kuipers EJ. Pernicious anemia, atrophic gastritis, and the risk of cancer. Clin Gastroenterol Hepatol. 2015;13(13):2290–2.
Article
Google Scholar
Murphy G, Dawsey SM, Engels EA, et al. Cancer risk after pernicious anemia in the US elderly population. Clin Gastroenterol Hepatol. 2015;13(13):2282-2289e4.
Article
Google Scholar
Ye W, Nyren O. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut. 2003;52(7):938–41.
Article
CAS
Google Scholar
Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37(4):375–82.
Article
CAS
Google Scholar
Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer A population-based cohort study. Cancer. 1993;71(3):745–50.
Article
CAS
Google Scholar
Brinton LA, Gridley G, Hrubec Z, et al. Cancer risk following pernicious anaemia. Br J Cancer. 1989;59(5):810–3.
Article
CAS
Google Scholar
Sjoblom SM, Sipponen P, Jarvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993;34(1):28–32.
Article
CAS
Google Scholar
Armbrecht U, Stockbrugger RW, Rode J, et al. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut. 1990;31(10):1105.
Article
CAS
Google Scholar
Lahner E, Caruana P, D’Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc. 2001;53(4):443–8.
Article
CAS
Google Scholar
Cai Q, Zhu C, Yuan Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–87.
Article
CAS
Google Scholar
Zagari RM, Rabitti S, Greenwood DC, et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46(7):657–67.
Article
CAS
Google Scholar
Syrjanen K. A panel of serum biomarkers (gastropanel(R)) in non-invasive diagnosis of atrophic gastritis systematic review and meta-analysis. Anticancer Res. 2016;36(10):5133–44.
Article
CAS
Google Scholar
Chen Z, Hong L, Liu L, et al. Monoclonal antibody MG7 as a screening tool for gastric cancer. Hybridoma. 2010;29(1):27–30.
Article
Google Scholar
Zhang L, Ren J, Pan K, et al. Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening. Int J Cancer. 2010;126(2):469–73.
Article
CAS
Google Scholar
Guo DL, Dong M, Wang L, et al. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases. World J Gastroenterol. 2002;8(6):1009–13.
Article
CAS
Google Scholar
Jiang J, Shen S, Dong N, et al. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases. Cancer Med. 2018;7(8):4068–76.
Article
CAS
Google Scholar
Yang Zhenhua SB, Huang AS, et al. Gastroscopic and pathological features of chronic atrophic gastritis syndrome. Chin J Integr Chin West Med Dig. 2021;29(1):58–61.
Google Scholar
Song J, Yuan MH, Liu ZH, et al. Association of serum pepsin levels with high risk syndromes of gastric precancerous lesions. Lishizhen Med Mater Med Res. 2020;31(7):1658–60.
Google Scholar
Yang Y, Qu XH, Yang M, et al. Association between TCM syndromes and cancer risk in chronic Atrophic gastritis patients. J Tradit Chin Med. 2020;61(4):319–24.
Google Scholar
Wang P, Shi B, Wen YD, Tang XD. Study on the establishment of risk prediction model for combination of syndrome and disease in gastric precancerous lesions. Chin J Integr Tradit West Med. 2018;38(7):773–8.
Google Scholar
Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol. 1993;6:281.
CAS
Google Scholar
Kawai T, Moriyasu F, Tsuchida A. Key issues associated with helicobacter pylori eradication. Digestion. 2016;93:19.
Article
Google Scholar
Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology. 2000;119:7.
Article
CAS
Google Scholar
Gong EJ, Kim DH, Ahn JY, et al. Effects of proton pump inhibitor on the distribution of Helicobacter pylori and associated gastritis in patients with gastric atrophy. Digestion. 2019;101:279.
Article
Google Scholar
Kitauchi OH, Yoshimura SN, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. IntJ Cancer. 2004;109:138–43.
Article
Google Scholar
Yi-Qi DU, Li G, Quan-Cai C, et al. Gastro-protecting effect of gefarnate on chronic erosive gastritis with dyspeptic symptoms. Chin Med J. 2012;125(16):2878–84.
Google Scholar
Yun CY, Kim N, Lee J, et al. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors. Helicobacter. 2018;23(6):e12542.
Article
Google Scholar
Mera RM, Bravo LE, Camargo MC, et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018;67(7):1239–46.
Article
Google Scholar
Rugge M, Meggio A, Pravadelli C, et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019;68(1):11–7.
Article
Google Scholar
Yamada H, Ikegami M, Shimoda T, et al. Long-term follow- up study of gastric adenoma/dysplasia. Endoscopy. 2004;36(5):390–6.
Article
CAS
Google Scholar
Kang DH, Choi CW, Kim HW, et al. Predictors of upstage diagnosis after endoscopic resection of gastric low-grade dysplasia. Surg Endosc. 2018;32(6):2732–8.
Article
Google Scholar
Yang L, Jin P, Wang X, et al. Risk factors associated with histological upgrade of gastric low-grade dysplasia on pretreatment biopsy. J Dig Dis. 2018;19(10):596–604.
Article
Google Scholar
Min B-H, Kim K-M, Kim ER, et al. Endoscopic and histopathological characteristics suggesting the presence of gastric mucosal high grade neoplasia foci in cases initially diagnosed as gastric mucosal low grade neoplasia by forceps biopsy in Korea. J Gastroenterol. 2011;46(1):17–24.
Article
Google Scholar
Svetlana K, Anna B, Oleg R, et al. Stomach-specific biomarkers (GastroPanel) can predict the development of gastric cancer in a caucasian population: a longitudinal nested case-control study in Sibera. Anticancer Res. 2016;36(1):247–53.
Google Scholar
Ryu DG, Choi CW, Kang DH, et al. Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia. Medicine. 2018;97(33):e11802.
Article
Google Scholar
Back MK, et al. Analysis of factors associated with local recurrence after endoscopic resection of gastric epithelial dysplasia: a retrospective study. BMC Gastroenterol. 2020;20(1):148.
Article
Google Scholar
Kwon MJ, Kang HS, Kim HT, et al. Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors. World J Gastroenterol. 2019;25(4):469–84.
Article
Google Scholar
Lee H, Kim H, Shin SK, et al. The Diagnostic role of endoscopic submucosal dissection for gastric lesions with indefinite pathology. Scand J Gastroenterol. 2012;47(8–9):1101–7.
Article
Google Scholar
Yu CH, Jeon SW, Kim SK, et al. Endoscopic resection as a first therapy for gastric epithelial atypia: is it reasonable? Dig Dis Sci. 2014;59(12):3012–20.
Article
Google Scholar
Beijing Science and Technology Commission Major Project “early gastric cancer treatment standard research” expert group. Expert consensus opinion on endoscopic standardized resection of early gastric cancer. Chin J Gastroenterol. 2018(2): 49–60.
Yuan JX. Endoscopic high-frequency electrocoagulation combined with Kangfuxin solution in the treatment of 32 gastrointestinal polyps. Guide Chin Med. 2008;15:144–5.
Google Scholar
Wen YP, Peng FY. Effect of kangfuxin solution on upper gastrointestinal polyp after electrotomy. Hainan Med. 2012;23(1):70–1.
Google Scholar
Wang HG, Wang Y, Guo QM. Kangfuxinye combined with pantoprazole in the treatment of gastric ulcer after gastrectomy. Chin J Integr Tradit West Med. 2013;21(7):382–3.
Google Scholar
Tang SB, Wang ML, Liang J, et al. Therapeutic effect of Jianweiyuyang tablet on precancerous lesion of stomach. J Mod Integr Chin West Med. 2009;18(30):3678–9.
Google Scholar
Wang CX, Wang QM, Song LW, et al. Jianweiyuyang tablets for the repair of iatrogenic ulcers after endoscopic surgery. Chin Med Innov. 2015;12(7):22–4.
CAS
Google Scholar
Wenzhong L, Yong X, Hong L, Hong C, Zhirong Z, Liya Z, Ye C, Jiangbin W, Yiqi D, Nonghua Lv. Fifth national consensus report on the management of helicobacter pylori infection. Chin J Int Med. 2017;56(7):532–45.
Xia ZW, Jiang GD. Experimental observation on anti-typhoid bacilli activity and in vitro compatibility of antibacterial drugs of gegenqinlian decoction. J Integr Chin West Med. 1996;9(7):394.
Google Scholar
Li T. A survey of research on prevention and treatment of bacterial resistance with traditional Chinese medicine. Chin J Med. 2001;16(3):29.
Google Scholar
Shi JB. Observation on the therapeutic effect of integrated traditional Chinese and western medicine on Helicobacter pylori patients. J Mod Integr Chin West Med. 2003;12(7):721.
Google Scholar
Hua ZM, Ma ZQ, Tong BL, et al. Helicobacter pylori therapy in combination with traditional Chinese medicine. Chin J Tradit Chin West Med. 2008;9(2):115–8.
Google Scholar
Shen XH, Cui ML. Progress in the treatment of drug resistant Helicobacter pylori with traditional Chinese and Western medicine. Fujian Med J. 2008;30(4):91–3.
Google Scholar
Wang ML, Liu JH, Mao LF, et al. Advance in diagnosis and treatment of gastric precancerous lesions. J Clin Chin Med. 2020;32(1):171–4.
Google Scholar
Jiang N, Huang X, Fan YH, et al. Systematic review of integrated traditional and western medicine in the treatment of gastric precancerous lesions. Chin J Tradit Chin Med. 2015;33(1):149–54.
Google Scholar
Lundell L, Miettinen P, Myrvold HE, et al. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group Gastroenterol. 1999;117(2):319–26.
CAS
Google Scholar
Eslami L, Nasseri-Moghaddam S. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions? Arch Iran Med. 2013;16(8):449–58.
Google Scholar
Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.CD010623.pub2.
Article
Google Scholar
Nasser SC, Slim M, Nassif JG, et al. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes. World J Gastroenterol. 2015;21(15):4599–606.
Article
CAS
Google Scholar
Niikura R, Hayakawa Y, Hirata Y, et al. The reduction in gastric atrophy after eradication is reduced by treatment with inhibitors of gastric acid secretion. Int J Mol Sci. 2019;20(8):1913.
Article
CAS
Google Scholar
Seo SI, Park CH, You SC, et al. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut. 2021;11:gutjnl-2020 323845.
Google Scholar
Dias-Neto M, Pintalhao M, Ferreira M, et al. Salt intake and risk of gastric intestinal metaplasia: systematic review and meta-analysis. Nutr Cancer. 2010;62(2):133–47.
Article
CAS
Google Scholar
Park YM, Kim JH, Baik SJ, et al. Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: an individualized consideration of the risk factors. Medicine (Baltimore). 2016;95(44):e5351.
Article
Google Scholar
Song JH, Kim YS, Heo NJ, et al. High salt intake is associated with atrophic gastritis with intestinal metaplasia. Cancer Epidemiol Biomarkers Prev. 2017;26(7):1133–8.
Article
Google Scholar
Thapa S, Fischbach LA, Delongchamp R, et al. Association between dietary salt intake and progression in the gastric precancerous process. Cancers. 2019;11(4):467.
Article
CAS
Google Scholar
Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer. 2006;119(1):196–201.
Article
CAS
Google Scholar
Ke L, Zhang D, Chen Y, et al. Investigation on the risk factors of intestinal metaplasia in Northwest China gastric mucosa. Adv Mod Biomed. 2016;16(34):6639–43.
Google Scholar
Yu Y, Fang C, Peng C, et al. Risk factors for gastric intraepithelial neoplasia in Chinese adults: a case-control study. Cancer Manag Res. 2018;10:2605–13.
Article
Google Scholar
Tan MC, Mallepally N, Liu Y, et al. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020;115:3.
Article
Google Scholar
Lahner E, Carabotti M, Esposito G, et al. Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms. Eur J Gastroenterol Hepatol. 2018;30(11):1291–6.
Article
Google Scholar
You WC, Li JY, Zhang L, Jin ML, et al. Etiology and prevention of gastric cancer: a population study in a high risk area of China. Chin J Dig Dis. 2005;6(4):149–54.
Article
Google Scholar
Xing J, Min L, Zhu S, et al. Factors associated with gastric adenocarcinoma and dysplasia in patients with chronic gastritis: a population-based study. Chin J Cancer Res. 2017;29(4):341–50.
Article
Google Scholar
Kim K, Chang Y, Ahn J, et al. Smoking and urinary cotinine levels are predictors of increased risk for gastric intestinal metaplasia. Cancer Res. 2019;79(3):676–84.
Article
CAS
Google Scholar
Peleteiro B, Lunet N, Figueiredo C, et al. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiol Biomarkers Prev. 2007;16(2):322–6.
Article
CAS
Google Scholar
Kato I, Vivas J, Plummer M, et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev. 2004;13(3):468–76.
Article
Google Scholar
Nakamura M, Haruma K, Kamada T, et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig Dis Sci. 2002;47(3):675–81.
Article
Google Scholar
Nieminen AA, Kontto J, Puolakkainen P, et al. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. Scand J Gastroenterol. 2019;54(2):145–51.
Article
Google Scholar
Nam JH, Choi IJ, Kook MC, et al. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Helicobacter. 2014;19(2):81–9.
Article
Google Scholar
Sobala GM, Pignatelli B, Schorah CJ, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis. 1991;12(2):193–8.
Article
CAS
Google Scholar
Sobala GM, O’Connor HJ, et al. Bile reflux and intestinal metaplasia in gastric mucosa. J ClinPathol. 1993;46(3):235–40.
CAS
Google Scholar
Matsuhisa T, Arakawa T, Watanabe T, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc. 2013;25(5):519–25.
Article
Google Scholar
Matsuhisa T, Tsukui T. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. J Clin Biochem Nutr. 2012;50(3):217–21.
Article
CAS
Google Scholar
Dixon MF, Mapstone NP, Neville PM, et al. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut. 2002;51(3):351–5.
Article
CAS
Google Scholar
Li D, Zhang J, Yao WZ, et al. The relationship between gastric cancer, its precancerous lesions and bile reflux: a retrospective study. J Dig Dis. 2020;21(4):222–9.
Article
Google Scholar
Zhang L, Zhang J, Li D, et al. Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: an observational cross-sectional study. J Dig Dis. 2021;22(5):282–90.
Article
Google Scholar
Jiang JX, Liu Q, Zhao B, et al. Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases. J Cancer Res Clin Oncol. 2017;143(3):409–18.
Article
Google Scholar
Tang XD, Zhou LY, Zhang ST, et al. Randomized double-blind clinical trial of moluodan for the treatment of chronic atrophic gastritis with dysplasia. Chin J Integr Med. 2016;22(1):9–18.
Article
CAS
Google Scholar
Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291(2):187–94.
Article
CAS
Google Scholar
Ma JL, Zhang L, Brown LM, et al. fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488–92.
Article
CAS
Google Scholar
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut. 2018;67(12):2092–6.
Article
Google Scholar
Leung WK, Wong IOL, Cheung KS, et al. Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals. Gastroenterology. 2018;155(1):67–75.
Article
Google Scholar
Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:g3174.
Article
Google Scholar
Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(5):427–36.
Article
Google Scholar
Chen HN, Wang Z, Li X, et al. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer. 2016;19(1):166–75.
Article
Google Scholar
Li WQ, Ma JL, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014;106(7):dju116.
Article
Google Scholar
Den Hollander WJ, Holster IL, den Hoed CM, et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut. 2019;68(4):585–93.
Article
Google Scholar
Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639–42.
CAS
Google Scholar
Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.
Article
Google Scholar
Choi J, Kim SG, Yoon H, et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol. 2014;12(5):791–800.
Article
Google Scholar
Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085–95.
Article
CAS
Google Scholar
Cheng H, Hu FL, Sheng JQ, et al. Jinghua Weikang capsule combined with triple or quadruple Furazolidone therapy for Helicobacter pylori infection: a multicenter, randomized, controlled study. Chin J Med. 2016;9640:3206–12.
Google Scholar
Li JX, Lu B, Du Q, et al. Jinghuaweikang capsule combined with bismuth quadruple in the treatment of Helicobacter pylori chronic gastritis. Chin J Integr Chin Western Med Dig. 2018;26(12):998–1004.
Google Scholar
He XM, Huang X. Combination of Weifuchun and quadruple therapy for H. Helicobacter pylori associated chronic Atrophic gastritis. World J Chin Dig. 2017;25(6):521–5.
Article
Google Scholar
Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr Cancer. 2005;53(1):1–10.
Article
Google Scholar
Kong P, Cai Q, Geng Q, et al. Vitamin intake reduce the risk of gastric cancer: meta-analysis and systematic review of randomized and observational studies. PLoS ONE. 2014;9(12):e116060.
Article
Google Scholar
Dawsey SP, Hollenbeck A, Schatzkin A, et al. A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers. PLoS ONE. 2014;9(2):e88774.
Article
Google Scholar
Li WQ, Zhang JY, Ma JL, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019;366:l5016.
Article
Google Scholar
Zhu SS, Mason Joel, Shi Y, et al. Effects of folic acid on the development of gastric cancer and other gastrointestinal cancers: a seven-year follow-up study. Chin J Gastroenterol. 2002;7(2):73–8.
Google Scholar
Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92(23):1881–8.
Article
CAS
Google Scholar
You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98(14):974–83.
Article
Google Scholar
Plummer M, Vivas J, Lopez G, et al. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst. 2007;99(2):137–46.
Article
CAS
Google Scholar
Taylor PR. Prevention of gastric cancer: a miss. J Natl Cancer Inst. 2007;99(2):101–3.
Article
Google Scholar
Wu YQ, Liu HM, Chai X. Analysis of factors influencing disease progression and mucosal outcome in patients with chronic Atrophic gastritis treated with folic acid and Helicobacter pylori. Jiangsu Medicine. 2018;44(11):1283–6.
Google Scholar
Dai YQ, Ye ZD, Huang HH. Long term effects of Helicobacter pylori plus folic acid in patients with chronic Atrophic gastritis. World J Chin Dig. 2017;25(19):1777–82.
Article
Google Scholar
Wei X, Qin DP. Systematic review of traditional Chinese medicine in the treatment of chronic Atrophic gastritis with dysplasia. J Zhejiang Chin Med Univ. 2013;37(7):864–9.
Google Scholar
Li F, Han J. Meta-analysis on effect of traditional Chinese medicine on gastric epithelial dysplasia. Chin Med Bulletin. 2017;23(14):108–12.
Google Scholar
Yang XY, Wu YL, Zhu YH, et al. A study on the treatment and prognosis of low-grade intraepithelial neoplasia of gastric mucosa with vernal fortification and folic acid. Theory Pract Inter Med. 2013;8(1):24–8.
Google Scholar
Cao YJ, Qu CM, Wu JH, et al. Efficacy of folic acid combined with metoclopramide in the treatment of Atrophic gastritis precancerous lesions. World J Chin Dig. 2013;21(30):3261–4.
Article
Google Scholar
Feng RB. Clinical study of MORODAN combined with folic acid in the treatment of chronic Atrophic gastritis with dysplasia. Hebei Tradit Chin Med. 2011;33(6):865–7.
Google Scholar
Zhong GX, Li SH. Evaluation of the quality of clinical randomized controlled trial reports for acupuncture treatment of chronic Atrophic gastritis based on CONSORT and STRICTA. Lishizhen Med Mater Med Res. 2013;24(4):983–6.
Google Scholar
Li JH, Feng Y, Luo LT. Data analysis and quality evaluation of TCM literature on chronic gastritis. World Tradit Chin Med. 2013;8(12):1490–2.
CAS
Google Scholar
Liu S, Su ZQ, Liu XY, et al. PubMed and web of science database: a literature analysis of the current status of traditional Chinese medicine in treating chronic atrophic gastritis. Chin J Exp Pharm. 2021;27(6):149–58.
Google Scholar
Kenneth FS, Douglas GA, David M, the CONSORT Group. Consort 2010 statement: report an update to the guidelines for parallel-controlled randomized clinical trials. J Integr Chin West Med. 2010;8(7):604–12.
Article
Google Scholar
Wang P, Zhang BH, Wang FY, Tang XD. Efficacy evaluation of gastric precancerous lesions. Med Philos. 2015;36(539):18–20.
Google Scholar
Li Y. Morphologic and molecular biological study of gastric dysplasia and dysplasia. Beijing: Peking Union Medical College Hospital; 2012.
Google Scholar